NSCLC STAGE IV
Clinical trials for NSCLC STAGE IV explained in plain language.
Never miss a new study
Get alerted when new NSCLC STAGE IV trials appear
Sign up with your email to follow new studies for NSCLC STAGE IV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Lung cancer drug trial halted early: what we know
Disease control TerminatedThis early-stage trial tested a new drug called MYTX-011 for people with advanced non-small cell lung cancer (NSCLC) that had spread or come back after standard treatments. The drug is an antibody-drug conjugate designed to deliver a powerful chemotherapy directly to cancer cells…
Matched conditions: NSCLC STAGE IV
Phase: PHASE1 • Sponsor: Mythic Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Lung cancer combo trial halted early: what we know
Disease control TerminatedThis study looked at whether adding a single dose of radiation to the immunotherapy drug atezolizumab could help people with advanced lung cancer whose disease had gotten worse after both chemotherapy and another type of immunotherapy. The trial planned to include 12 adults with …
Matched conditions: NSCLC STAGE IV
Phase: PHASE2 • Sponsor: Oncology Institute of Southern Switzerland • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC